HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Papamichail Selected Research

Neoplasms (Cancer)

9/2019Safety and Efficacy of Inferior Vena Cava Reconstruction During Hepatic Resection.
1/2016Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
9/2003Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumours.
4/2003Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells.
10/2002Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants.
3/2001A novel culture environment for generating mature human dentritic cells from peripheral blood CD14+ cells.
10/2000Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas.
7/2000Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice.
4/2000Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Papamichail Research Topics

Disease

9Neoplasms (Cancer)
09/2019 - 04/2000
2Breast Neoplasms (Breast Cancer)
01/2016 - 11/2001
1Triple Negative Breast Neoplasms
01/2016
1Prostatic Neoplasms (Prostate Cancer)
09/2003
1Melanoma (Melanoma, Malignant)
11/2001
1Carcinoma (Carcinomatosis)
10/2000
1Fibrosarcoma
07/2000

Drug/Important Bio-Agent (IBA)

4Peptides (Polypeptides)IBA
01/2016 - 04/2000
2EpitopesIBA
09/2003 - 11/2001
2CytokinesIBA
04/2003 - 10/2002
2Interleukin-2 (IL2)IBA
10/2000 - 04/2000
1AE37 vaccineIBA
01/2016
1Hormones (Hormone)IBA
01/2016
1VaccinesIBA
01/2016
1HLA-A3 Antigen (HLA A3 Antigen)IBA
09/2003
1HLA-A*26 antigenIBA
09/2003
1Oncogene Proteins (Oncogene Protein)IBA
09/2003
1HLA-A2 Antigen (HLA A2 Antigen)IBA
09/2003
1zeta receptorIBA
04/2003
1HLA-DR Antigens (HLA-DR)IBA
11/2001
1HER2(776-788)IBA
11/2001
1Complementary DNA (cDNA)IBA
11/2001
1HLA-DRB5 Chains (HLA DRB5)IBA
11/2001
1Interleukin-12 (IL 12)IBA
03/2001
1prothymosin alphaIBA
10/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2000
1LigandsIBA
04/2000
1Interleukin-7 (Interleukin 7)IBA
04/2000

Therapy/Procedure

2Immunotherapy
10/2002 - 03/2001
1Liver Transplantation
09/2019
1Hepatectomy
09/2019
1Therapeutics
09/2003